Home > Insider Trading > Filing (0000904454-13-001086)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1488039	Atossa Genetics Inc	ATOS	Surgical & Medical Instruments & Apparatus (3841)	264753208

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1552127	Shu-Chih Chen	4105 E. Madison Street, Suite 320 Seattle WA 98112	Chief Scientific Officer	Yes	Yes	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2013-10-01	7,265	$5.66	4,268,315	No	4	S	Indirect	By Ensisheim Partners, LLC

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	By Ensisheim Partners, LLC

Footnotes

The sales reported on this Form 4 were effected pursuant to a trading plan previously adopted pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. The trading plan was previously reviewed and approved by the Company's board of directors in accordance with Rule 10b5-1.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.57 to $5.82, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.
Ensisheim Partners, LLC is wholly owned by the Reporting Person and Dr. Steven Quay, the Chief Executive Officer of the Company. The Reporting Person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of all such securities for purposes of Section 16 or any other purpose.